BEAT Tim Cruickshank buys $30K worth of shares
Feb 22, 2025, 5:33 AM
1.54%
What does BEAT do
HeartBeam, a development stage company based in Santa Clara, California, focuses on advanced cardiovascular diagnostic technology and went public on October 14, 2021. They are developing proprietary VECG technology and two patented products, HeartBeam AIMI and HeartBeam AIMIGo, for cardiac disease detection and monitoring.
Tim Cruickshank bought 17,647 shares of BEAT on 14 February at $1.70 per share, worth a total of $30K. They now own 17,647 BEAT shares.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.